1. Home
  2. BNTC vs VSTA Comparison

BNTC vs VSTA Comparison

Compare BNTC & VSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • VSTA
  • Stock Information
  • Founded
  • BNTC 1995
  • VSTA 1966
  • Country
  • BNTC United States
  • VSTA Brazil
  • Employees
  • BNTC N/A
  • VSTA N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • VSTA Other Consumer Services
  • Sector
  • BNTC Health Care
  • VSTA Real Estate
  • Exchange
  • BNTC Nasdaq
  • VSTA Nasdaq
  • Market Cap
  • BNTC 365.1M
  • VSTA 397.5M
  • IPO Year
  • BNTC N/A
  • VSTA 2020
  • Fundamental
  • Price
  • BNTC $13.90
  • VSTA $4.93
  • Analyst Decision
  • BNTC Strong Buy
  • VSTA
  • Analyst Count
  • BNTC 5
  • VSTA 0
  • Target Price
  • BNTC $24.80
  • VSTA N/A
  • AVG Volume (30 Days)
  • BNTC 40.3K
  • VSTA 56.7K
  • Earning Date
  • BNTC 11-13-2025
  • VSTA 11-06-2025
  • Dividend Yield
  • BNTC N/A
  • VSTA N/A
  • EPS Growth
  • BNTC N/A
  • VSTA N/A
  • EPS
  • BNTC N/A
  • VSTA 1.09
  • Revenue
  • BNTC N/A
  • VSTA $313,466,268.00
  • Revenue This Year
  • BNTC N/A
  • VSTA $11.22
  • Revenue Next Year
  • BNTC N/A
  • VSTA $13.43
  • P/E Ratio
  • BNTC N/A
  • VSTA $4.56
  • Revenue Growth
  • BNTC N/A
  • VSTA 8.99
  • 52 Week Low
  • BNTC $9.09
  • VSTA $1.60
  • 52 Week High
  • BNTC $17.15
  • VSTA $5.49
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 54.74
  • VSTA 64.31
  • Support Level
  • BNTC $13.49
  • VSTA $4.89
  • Resistance Level
  • BNTC $14.01
  • VSTA $4.98
  • Average True Range (ATR)
  • BNTC 0.54
  • VSTA 0.09
  • MACD
  • BNTC -0.04
  • VSTA -0.02
  • Stochastic Oscillator
  • BNTC 64.70
  • VSTA 81.10

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

Share on Social Networks: